Why Susser Holdings, Furiex Pharmaceuticals, and AstraZeneca Are Today's 3 Best Stocks

Merger mania drives the S&P 500 higher, with Susser Holdings, Furiex Pharmaceuticals, and AstraZeneca leading the way.

Apr 28, 2014 at 5:15PM

Another "Merger Monday" lit a fire beneath investors and the S&P 500 with merger and acquisition rumblings and announcements signaling to investors that businesses are still willing to take on risks in order to expand. The end result was yet another up day for the broad-based index.


Also helping to push the index higher was surprisingly strong pending home sales data for March. Following eight consecutive months of declines, optimists were given a treat via a 3.4% increase in pending home sales, likely thanks to the combination of historically low lending rates driving homebuyers to take the plunge and warmer weather encouraging them to purchase their dream home. Still, even after this March report, I'd caution investors that homebuyers have been incredibly sensitive to interest rate swings, and just last quarter mortgage servicing companies generated their lowest cumulative loan totals in 14 years. This is a sector that could still be ripe for a downturn.

With M&A in mind, better than expected housing data, and dozens of large multinational corporations set to report earnings this week, investors had no problem pushing the S&P 500 higher by 6.03 points (0.32%) to close at 1,869.43.


Source: Susser Holdings.

Leading all stocks to the upside was Susser Holdings (NYSE:SUSS), which surged 36.3% after it agreed to be acquired by Energy Transfer Partners (NYSE:ETP) for $1.8 billion. Under the terms of the deal, Susser stockholders will have the option of receiving either $80.25 in cash, 1.4056 Energy Transfer Partners common units, or a combination of both, for every share they own. It appears to be a great deal for all parties involved, enabling Energy Transfer Partners to take advantage of Susser's growing retail presence that now covers hundreds of convenience stores. ETP also gets general partner ownership of Susser Petroleum Partners, giving it incentive distribution rights. Susser shareholders get a premium of roughly 18 times its trailing operating cash flow, which seems more than fair.

Also taking advantage of M&A mania today was biopharmaceutical development company Furiex Pharmaceuticals (UNKNOWN:FURX.DX), which skyrocketed 28.6% after agreeing to be acquired by Forest Laboratories for $1.46 billion. Furiex shareholders will receive $95 per share in cash and could receive up to an additional $30 per share contingent on the approval of late-stage diarrhea-predominant irritable bowel syndrome drug eluxadoline. Upon closing of the deal, Forest Labs plans to sell most of Furiex's royalty rights business to Royalty Pharma for $415 million. Actavis, which is actually in the process of purchasing Forest Labs, gave its thumbs-up to the deal. While I'd be doing a jig if I were a Furiex shareholder, I'm not quite certain that, even with positive late-stage results from Furiex, Forest Labs didn't overpay. There's still enough uncertainty surrounding eluxadoline that I'm not sold on this being a smart deal for Forest or Actavis just yet.

Astrazeneca Chemistry

Source: AstraZeneca.

Finally, and sticking with the health-care sector, pharmaceutical behemoth AstraZeneca (NYSE:AZN) advanced by 12.2% after confirming that it had indeed been approached by Pfizer (NYSE:PFE)in January with an acquisition bid of roughly $98.7 billion, according to CNBC. Even after being turned down twice by AstraZeneca, which argues that Pfizer's offer clearly undervalues the company, Pfizer isn't deterred one bit. This has investors hopeful that there could be another even larger offer on the way. Given AstraZeneca's pipeline struggles and patent expirations, the combination may not be a bad idea, and it would certainly make sense in my eyes from a strategic and pipeline standpoint. From the viewpoint of Pfizer, however, I would be extremely reluctant to pay even more for AstraZeneca's unexciting pipeline at this point.

These M&A announcements and rumors sent these three stocks soaring, but over the long haul they could have a tough time keeping up with this top stock
Give me five minutes and I'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks 1 stock with amazing potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303%! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.

Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers